Amphetamine-induced movement disorder

Emerg Med Australas. 2005 Jun;17(3):277-80. doi: 10.1111/j.1742-6723.2005.00735.x.

Abstract

Recreational use of amphetamines is common in Australia and New Zealand when compared with other developed nations. The clinical effects are variable because of the potential of these drugs to increase the proportion of different biogenic amines in the central nervous system (CNS). The substances affected are adrenaline, noradrenaline, serotonin and dopamine. Movement disorders represent one of the less common presentations of amphetamine toxicity but one that health care workers should be aware of nonetheless.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Amphetamine-Related Disorders / complications*
  • Amphetamines / adverse effects*
  • Amphetamines / pharmacology
  • Chlorpromazine / therapeutic use
  • Chorea / chemically induced*
  • Chorea / physiopathology
  • Dopamine Antagonists / therapeutic use
  • Humans
  • Neurotoxicity Syndromes / etiology*
  • Neurotoxicity Syndromes / physiopathology

Substances

  • Amphetamines
  • Dopamine Antagonists
  • Chlorpromazine